Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Camici

Showing results (21-30 of 122) with videos related to

Pageof 13
Sort By:
Minerva Medica|July 1, 1999
Tissue factor pathway inhibitorM Camici, A Sagripanti
Minerva Medica|September 11, 2002
[Cardiovascular prevention: new biochemical plasmatic markers of risk]M Camici, A Sagripanti
La Clinica Terapeutica|February 28, 1991
[Heparin therapy and its monitoring]M Camici, L Evangelisti
Minerva Medica|February 1, 1993
[Activated partial thromboplastin time. Evaluation of sensitivity and validity for determination of factor VIII coagulant activity]M Camici, L Evangelisti
La Clinica Terapeutica|January 1, 1993
[Heparinization in dialysis: new clinico-therapeutic directions]M Camici, L Evangelisti
Angiology|April 1, 1989
Heparin and prostacyclinM Camici, L Evangelisti
Recenti Progressi in Medicina|November 1, 1989
[Membrane signals: role of the inositol phosphate system]L Malanca, M Camici
Analytical Biochemistry|March 15, 1981
An enzymatic radioactive assay to determine ribose 1-phosphate in tissuesP L Ipata, M Camici
Recenti Progressi in Medicina|April 1, 1991
[Heparin anticoagulant activity: new knowledge and future prospects]M Camici, C Giusti, L Evangelisti
Current Topics in Cellular Regulation|January 1, 1985
In situ regulation studies of Escherichia coli glutamine synthetaseU Mura, M Camici, S Gini
Pageof 13

Showing results (21-30 of 122) with videos related to

Sort By:
Pageof 13
Minerva Medica|July 1, 1999
Tissue factor pathway inhibitorM Camici, A Sagripanti
Minerva Medica|September 11, 2002
[Cardiovascular prevention: new biochemical plasmatic markers of risk]M Camici, A Sagripanti
La Clinica Terapeutica|February 28, 1991
[Heparin therapy and its monitoring]M Camici, L Evangelisti
Minerva Medica|February 1, 1993
[Activated partial thromboplastin time. Evaluation of sensitivity and validity for determination of factor VIII coagulant activity]M Camici, L Evangelisti
La Clinica Terapeutica|January 1, 1993
[Heparinization in dialysis: new clinico-therapeutic directions]M Camici, L Evangelisti
Angiology|April 1, 1989
Heparin and prostacyclinM Camici, L Evangelisti
Recenti Progressi in Medicina|November 1, 1989
[Membrane signals: role of the inositol phosphate system]L Malanca, M Camici
Analytical Biochemistry|March 15, 1981
An enzymatic radioactive assay to determine ribose 1-phosphate in tissuesP L Ipata, M Camici
Recenti Progressi in Medicina|April 1, 1991
[Heparin anticoagulant activity: new knowledge and future prospects]M Camici, C Giusti, L Evangelisti
Current Topics in Cellular Regulation|January 1, 1985
In situ regulation studies of Escherichia coli glutamine synthetaseU Mura, M Camici, S Gini
Pageof 13